Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?

Exploring biomarkers in head and neck cancer

(2012) Corey J. Langer   CANCER

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions

(2012) Miroslaw J. Szczepanski et al.   ORAL ONCOLOGY

PRAME-Specific Allo-HLA-Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer

(2011) A. L. Amir et al.   CLINICAL CANCER RESEARCH

Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells

(2011) C. Visus et al.   CLINICAL CANCER RESEARCH

Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells

(2011) Norina Tanaka et al.   LEUKEMIA RESEARCH

All Trans Retinoic Acid and Cancer

(2010) Siddikuzzaman et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Retinoids regulate stem cell differentiation

(2010) Lorraine J. Gudas et al.   JOURNAL OF CELLULAR PHYSIOLOGY

All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells

(2010) Ruo-Jing Li et al.   JOURNAL OF CONTROLLED RELEASE

Early Detection of Premalignant Lesions and Oral Cancer

(2010) Toby O. Steele et al.   OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA

Vaccination With a Recombinant Protein Encoding the Tumor-specific Antigen NY-ESO-1 Elicits an A2/157-165-specific CTL Repertoire Structurally Distinct and of Reduced Tumor Reactivity Than That Elicited by Spontaneous Immune Responses to NY-ESO-1-expressing Tumors

(2009) Gilles Bioley et al.   JOURNAL OF IMMUNOTHERAPY